CXCL1 and acute myeloid leukemia: Since GroA was previously shown to be beneficial in terms of cancer treatment22 and has even been examined in phase II clinical trials for treatment of acute myeloid leukemia (AML)23, we sought to determine whether it had a similar effect on breast cancer in vivo.